MedPath

Epicardial Adipose Tissue Thickness and the Related Factors in Patients With Ankylosing Spondylitis

Completed
Conditions
Ankylosing Spondylitis
Registration Number
NCT06094686
Lead Sponsor
Istanbul Physical Medicine Rehabilitation Training and Research Hospital
Brief Summary

The aim of this study was to assess the EATT and the related factors in patients with AS and to compare the results with that of the healthy controls'

Detailed Description

The aim of this study was to investigate the epicardial adipose tissue thickness (EATT) and the related factors in patients with ankylosing spondylitis (AS) and to compare the results with those of the healthy controls. This cross-sectional study comprised thirty patients diagnosed with AS based on the modified New York criteria. The control group consisted of 31 healthy volunteers. Demographic characteristics were recorded. EATT was measured via transthoracic echocardiography. Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Metrology Index (BASMI), Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life (ASQoL), International Physical Activity Questionnaire Short Form (IPAQ-Short Form) were used. Functional capacity assessment was conducted using the six-minute walk test (6MWT).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
61
Inclusion Criteria
  • Disease duration >1 year,
  • Being ≥18 years
  • AS diagnosis according to modified New York Criteria
Exclusion Criteria
  • Being illiterate,
  • >65 years,
  • History of ischemic heart disease,
  • Cerebrovascular disease,
  • Hypertension,
  • Chronic kidney failure,
  • endocrinopathies like diabetes mellitus,
  • hypothyroidism,
  • Cushing syndrome and primary hyperlipidemia.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Epicardial adipose tissue thicknessthrough study completion, an average of 5 months

Epicardial adipose tissue thickness is measured via transthoracic echocardiography

Secondary Outcome Measures
NameTimeMethod
Bath Ankylosing Spondylitis Metrology Indexthrough study completion, an average of 5 months

The index helps to evaluate spinal mobility of AS patients. Higher scores indicate more limited mobility.

Ankylosing Spondylitis Disease Activity Scorethrough study completion, an average of 5 months

This score is used to evaluate disease activity of AS patients. Higher scores indicate that higher activity.

Ankylosing Spondylitis Quality of Lifethrough study completion, an average of 5 months

it is used for evaluate quality of life of AS patients. A lower score indicates better quality of life

International Physical Activity Questionnaire Short Formthrough study completion, an average of 5 months

it is used for evaluate patient's physical activity. Scoring a high level of physical activity on the IPAQ means your physical activity levels equate to approximately one hour of activity per day or more at least a moderate intensity activity level.

Bath Ankylosing Spondylitis Functional Indexthrough study completion, an average of 5 months

The index helps to evaluate disease activity of AS patients. High scores indicate that worse functional status.

Six minute walk testthrough study completion, an average of 5 months

This test is used to evaluate the patient's functional capacity. In case of low functional capacity, lower scores are observed. Higher scores indicate that higher activity.

Bath Ankylosing Spondylitis Disease Activity Indexthrough study completion, an average of 5 months

The index indicates that disease activity of AS patients. Higher scores indicate that higher activity

Trial Locations

Locations (1)

Istanbul Physical Medicine Rehabilitation Training and Research Hospital

🇹🇷

Istanbul, Turkey

Istanbul Physical Medicine Rehabilitation Training and Research Hospital
🇹🇷Istanbul, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.